Citadel Advisors LLC 13D/13G Filings for Pieris Pharmaceuticals, Inc. (PIRS)

Citadel Advisors LLC 13D and 13G filings for Pieris Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
06:22 am
Sale
2021-12-3113GPIERIS PHARMACEUTICALS INC
PIRS
Citadel Advisors LLC40,760
4.500%
-776decrease
(-1.87%)
Filing